Links between triglyceride levels, hepatitis C virus infection and diabetes [5]

Gut

Volumn 56, Issue 8, 2007, Pages 1167-1168

  Dai, Chia Yen ^a   Huang, Jee Fu ^a   Hsieh, Ming Yen ^a   Lee, Li Po ^a   Hou, Nai Jen ^a   Yu, Ming Lung ^a   Chuang, Wan Long ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; TRIACYLGLYCEROL; VIRUS RNA;

BODY MASS; DIABETES MELLITUS; ENDEMIC DISEASE; HEPATITIS C; HUMAN; LETTER; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS INFECTION;

ADULT; AGED; DIABETES COMPLICATIONS; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; TRIGLYCERIDES;

EID: 34547219840     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004;126:840-8.
2. Perlemuter G, Sabile A, Letteron P, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secreation: a model of viral-related steatosis. FASEB J 2002;16:185-94.
3. Serfaty L, Andreani T, Giral P, et al. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001;34:428-34.
4. Dai CY, Chuang WL, Chang WY, et al. Tumor necrosis factor alpha promoter polymorphism at position -308 predicts hepatitis C virus response to combination therapy. J Infect Dis 2006;193:98-101.